Dispersin B: Biofilm Disruption Research and Antibiofilm Applications

Introduction

Dispersin B is a glycoside hydrolase enzyme (EC 3.2.1.52) produced by the oral bacterium Aggregatibacter actinomycetemcomitans. With a molecular weight of approximately 40 kDa, Dispersin B catalyzes the hydrolysis of poly-N-acetylglucosamine (PNAG) — a key structural polysaccharide in the biofilms of numerous clinically relevant bacterial species. This enzymatic activity has positioned Dispersin B as a valuable research tool for studying biofilm biology, developing antibiofilm strategies, and investigating the role of PNAG in chronic infections.

Molecular Structure & Enzymatic Properties

Dispersin B belongs to the glycoside hydrolase family 20 (GH20) and cleaves β-1,6-linked N-acetylglucosamine residues within PNAG polymers. The enzyme's active site contains a conserved catalytic dyad (Asp-Glu) characteristic of GH20 enzymes. Dispersin B demonstrates broad substrate specificity across PNAG-producing organisms and retains activity across a pH range of 4.5–7.5, with optimal activity near pH 5.5–6.0 [1].

Mechanism of Action

Dispersin B disrupts biofilms through direct enzymatic degradation of the PNAG matrix:

1. PNAG hydrolysis: Dispersin B cleaves the β-1,6-glycosidic bonds of PNAG, depolymerizing the structural scaffold that holds biofilm communities together
2. Biofilm dispersal: PNAG degradation causes bacteria to detach from surfaces and revert to a planktonic state, increasing their susceptibility to antibiotics and immune clearance
3. Synergistic sensitization: Biofilm-dispersed bacteria show dramatically increased sensitivity to conventional antibiotics — studies have reported 100–1000-fold reductions in minimum biofilm eradication concentration (MBEC) when Dispersin B is combined with antibiotics [2]

Target Organisms

Dispersin B has demonstrated biofilm-disrupting activity against PNAG-producing organisms including:

- Staphylococcus epidermidis (major medical device biofilm pathogen) - Staphylococcus aureus (including MRSA strains) - Aggregatibacter actinomycetemcomitans (periodontal pathogen) - Escherichia coli (certain strains producing PNAG/PGA) - Yersinia pestis

Importantly, Dispersin B is not effective against organisms that use non-PNAG biofilm matrices (e.g., alginate-based Pseudomonas aeruginosa biofilms), making it a selective research tool for PNAG-dependent biofilm studies [3].

Research Applications

Medical Device Contamination Models

A primary research application of Dispersin B is in models of medical device-associated biofilm infections, particularly those involving staphylococcal species on implants, catheters, and prosthetic devices [4].

Combination Antimicrobial Research

Dispersin B has been extensively studied as a combination partner for antibiotics in biofilm eradication research. Published research has demonstrated synergistic killing when Dispersin B is combined with cefamandole nafate, triclosan, daptomycin, rifampin, and tigecycline [5].

Periodontal Research

Given Dispersin B's origin in A. actinomycetemcomitans, it has been studied in models of periodontal biofilm disruption and the enhancement of antimicrobial agents in periodontal infection models [6].

---

This article is intended for scientific and educational reference within a laboratory research context only. All products sold by Pure Pharm Peptides are for research use only and are not intended for human or animal consumption.

References

1. Kaplan, J.B., et al. (2003). Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans biofilms. Journal of Bacteriology, 185(13), 3918–3928.
2. Kaplan, J.B., et al. (2004). Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity. Journal of Bacteriology, 185(16), 4693–4698.
3. Itoh, Y., et al. (2005). Roles of pgaABCD genes in synthesis, modification, and export of the Escherichia coli biofilm adhesin poly-beta-1,6-N-acetyl-D-glucosamine. Journal of Bacteriology, 187(8), 2749–2760.
4. Cerca, N., et al. (2005). Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture. Journal of Antimicrobial Chemotherapy, 56(2), 331–336.
5. Kaplan, J.B., et al. (2012). Synergistic killing of Staphylococcus aureus biofilm by Dispersin B and a novel RNAIII inhibiting peptide. Antimicrobial Agents and Chemotherapy, 56(5), 2695–2699.
6. Izano, E.A., et al. (2007). Poly-N-acetylglucosamine mediates biofilm formation and antibiotic resistance in Actinobacillus pleuropneumoniae. Microbial Pathogenesis, 43(1), 1–9.

See Also: Dispersin B Protocols for Biofilm Research · Biofilm Research Methods Overview · Antibiofilm Peptide Strategies in Research